Mirxes晶泰强强联手!从早筛到诊疗,千亿赛道引爆价值重估

和讯网
Dec 05, 2025

今日,港股生物科技板块出现战略性合作动向。专注于癌症早期筛查的Mirxes (02629.HK)宣布与AI医药平台公司晶泰科技(02228.HK)达成合作,双方旨在整合各自在早期检测与药物研发方面的优势,共同探索针对亚洲高发癌症的"诊疗一体化"解决方案,此举被视为对癌症防控价值链的一次重要整合尝试。合作模式:构建"检测+研发"的闭环生态根据已披露的框架,此次合作的核心在于能力互补与数据驱动:? ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10